STSA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 birž. 2023 @ 23:00):

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device...

Stats
Dzisiejszy wolumen	1.83M
Średni wolumen	1.11M
Kapitalizacja rynkowa	36.47M
EPS	$0 ( 2024-03-26 )
Następna data zysków	( $0 ) 2024-05-09
Last Dividend	$0.200 ( 2014-03-28 )
Next Dividend	$0 ( N/A )
P/E	-0.553
ATR14	$0.0510 (4.64%)

Insider Trading

Date	Person	Action	Amount	type
2023-06-08	Ra Capital Management, L.p.	Sell	5 914 252	Common Stock
2023-06-08	Ra Capital Management, L.p.	Sell	10 000	Stock Option (Right to Buy)
2023-06-08	Ra Capital Management, L.p.	Sell	20 000	Stock Option (Right to Buy)
2023-06-08	Ra Capital Management, L.p.	Sell	30 000	Stock Option (Right to Buy)
2023-06-06	O'neil Thomas P.	Sell	13 877	Common Stock, $0.0001 par value

INSIDER POWER
54.69
Last 97 transactions
Buy: 62 291 817 \| Sell: 17 994 879

Wolumen Korelacja

Długi: 0.14 (neutral)

Krótki: 0.49 (neutral)

Signal:(60.819) Neutral

Satsuma Pharmaceuticals Korelacja

10 Najbardziej pozytywne korelacje
NRBO	0.956
DLTH	0.937
NXTC	0.934
TFFP	0.933
TOI	0.93
AGLE	0.923
PRTK	0.923
VIAV	0.917
ONCS	0.914
SGRP	0.914

10 Najbardziej negatywne korelacje
AGFS	-0.944
APEN	-0.938
PRDO	-0.932
NRIM	-0.92
FANH	-0.916
VLYPO	-0.916
UFPT	-0.916
MACK	-0.914
TSBK	-0.91
AMRB	-0.906

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Satsuma Pharmaceuticals Korelacja - Waluta/Towar

0.31
( neutral )

0.35
( neutral )

0.00
( neutral )

0.16
( neutral )

-0.25
( neutral )

0.12
( neutral )

Satsuma Pharmaceuticals Finanse

Annual	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-2.16

FY	2022
Przychody:	$0
Zysk brutto:	$0 (0.00 %)
EPS:	$-2.16

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.623

FY	2020
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-2.73

Financial Reports:

No articles found.

Satsuma Pharmaceuticals Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Satsuma Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$0.150	2012-12-19
Last Dividend	$0.200	2014-03-28
Next Dividend	$0	N/A
Payout Date	2014-04-15
Next Payout Date	N/A
# dividends	7	--
Total Paid Out	$1.500	--
Avg. Dividend % Per Year	0.00%	--
Score	1.57	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-10)

$0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

1.57

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-1.086	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	1.339	1.500	10.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.44	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	7.09	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.35	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00267	-1.500	9.96	-10.00	[0 - 0.6]
interestCoverageTTM	107.96	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	-1.113	2.00	-0.371	-0.742	[0 - 30]
freeCashFlowPerShareTTM	-1.117	2.00	-0.559	-1.117	[0 - 20]
debtEquityRatioTTM	0.00308	-1.500	9.99	-10.00	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-318.09	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.51

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.773	1.000	-0.179	0	[1 - 100]
returnOnEquityTTM	1.339	2.50	1.152	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.117	2.00	-0.372	-1.117	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.113	2.00	-0.371	-0.742	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00534	1.500	-3.30	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-0.623

Satsuma Pharmaceuticals